These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 20541396

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.
    Cesinaro AM, Sartori G, Migaldi M, Schirosi L, Pellacani G, Collina G, Maiorana A.
    Pathology; 2012 Jun; 44(4):313-7. PubMed ID: 22544212
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MGMT as a potential stratification marker in relapsed high-grade glioma of children: the HIT-GBM experience.
    Schlosser S, Wagner S, Mühlisch J, Hasselblatt M, Gerss J, Wolff JE, Frühwald MC.
    Pediatr Blood Cancer; 2010 Feb; 54(2):228-37. PubMed ID: 19856394
    [Abstract] [Full Text] [Related]

  • 5. Promoter CpG island hypermethylation of the DNA repair enzyme MGMT predicts clinical response to dacarbazine in a phase II study for metastatic colorectal cancer.
    Amatu A, Sartore-Bianchi A, Moutinho C, Belotti A, Bencardino K, Chirico G, Cassingena A, Rusconi F, Esposito A, Nichelatti M, Esteller M, Siena S.
    Clin Cancer Res; 2013 Apr 15; 19(8):2265-72. PubMed ID: 23422094
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic and predictive roles of MGMT protein expression and promoter methylation in sporadic pancreatic neuroendocrine neoplasms.
    Schmitt AM, Pavel M, Rudolph T, Dawson H, Blank A, Komminoth P, Vassella E, Perren A.
    Neuroendocrinology; 2014 Apr 15; 100(1):35-44. PubMed ID: 25012122
    [Abstract] [Full Text] [Related]

  • 8. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression.
    Uccella S, Cerutti R, Placidi C, Marchet S, Carnevali I, Bernasconi B, Proserpio I, Pinotti G, Tibiletti MG, Furlan D, Capella C.
    J Clin Pathol; 2009 Aug 15; 62(8):715-23. PubMed ID: 19638543
    [Abstract] [Full Text] [Related]

  • 9. Is MGMT promoter methylation to be considered in the decision making for recurrent surgery in glioblastoma patients?
    Pala A, Schmitz AL, Knoll A, Schneider M, Hlavac M, König R, Wirtz CR, Coburger J.
    Clin Neurol Neurosurg; 2018 Apr 15; 167():6-10. PubMed ID: 29425743
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.
    Bedikian AY, Millward M, Pehamberger H, Conry R, Gore M, Trefzer U, Pavlick AC, DeConti R, Hersh EM, Hersey P, Kirkwood JM, Haluska FG, Oblimersen Melanoma Study Group.
    J Clin Oncol; 2006 Oct 10; 24(29):4738-45. PubMed ID: 16966688
    [Abstract] [Full Text] [Related]

  • 13. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging.
    Drabycz S, Roldán G, de Robles P, Adler D, McIntyre JB, Magliocco AM, Cairncross JG, Mitchell JR.
    Neuroimage; 2010 Jan 15; 49(2):1398-405. PubMed ID: 19796694
    [Abstract] [Full Text] [Related]

  • 14. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 15; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 15. O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancers.
    Wu PF, Kuo KT, Kuo LT, Lin YT, Lee WC, Lu YS, Yang CH, Wu RM, Tu YK, Tasi JC, Tseng HM, Tseng SH, Cheng AL, Lin CH.
    Lung Cancer; 2010 Jun 15; 68(3):484-90. PubMed ID: 19740564
    [Abstract] [Full Text] [Related]

  • 16. Methylthioadenosine phosphorylase represents a predictive marker for response to adjuvant interferon therapy in patients with malignant melanoma.
    Meyer S, Wild PJ, Vogt T, Bataille F, Ehret C, Gantner S, Landthaler M, Klinkhammer-Schalke M, Hofstaedter F, Bosserhoff AK.
    Exp Dermatol; 2010 Aug 15; 19(8):e251-7. PubMed ID: 20500769
    [Abstract] [Full Text] [Related]

  • 17. Prognostic factors in metastatic melanoma patients treated with biochemotherapy and maintenance immunotherapy.
    Minor DR, Moore D, Kim C, Kashani-Sabet M, Venna SS, Wang W, Boasberg P, O'Day S.
    Oncologist; 2009 Oct 15; 14(10):995-1002. PubMed ID: 19776094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MGMT promoter methylation is associated with temozolomide response and prolonged progression-free survival in disseminated cutaneous melanoma.
    Tuominen R, Jewell R, van den Oord JJ, Wolter P, Stierner U, Lindholm C, Hertzman Johansson C, Lindén D, Johansson H, Frostvik Stolt M, Walker C, Snowden H, Newton-Bishop J, Hansson J, Egyházi Brage S.
    Int J Cancer; 2015 Jun 15; 136(12):2844-53. PubMed ID: 25400033
    [Abstract] [Full Text] [Related]

  • 20. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 15; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.